Clinical Trial

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 (\[14C\]) GRT6019
Protocol Amendment History 3 changes
critical Trial completed 2026-08-13
critical Recruitment opened 2026-04-02
notable Primary completion pushed: 2026-03-26 -> 2026-06-06 2026-04-02
Trial Details
NCT Number NCT07479745
Lead Sponsor Grünenthal GmbH
Conditions Healthy Male Volunteers
Enrollment 10 participants
Start Date 2026-03-25
Primary Completion 2026-06-18 (estimated)
Study Completion 2026-06-18 (estimated)
Updated on ClinicalTrials.gov 2026-08-12